Abiomed Expands Heart Recovery Biz With New Circulatory Support Console

Abiomed is banking on its iPulse console, approved by FDA Dec. 18, to drive sales across its full acute cardiac assist portfolio and provide entrée into the $200 million intra-aortic balloon market